SCHEMBL30772401

SCHEMBL30772401

O=[N+]([O-])c1c(Br)cccc1Oc1ccccc1C(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSPB1 P04792 2/20 0.33
TLR8 Q9NR97 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PMM2 O15305 1/20 0.32
MPI P34949 1/20 0.32
TDP1 Q9NUW8 3/20 0.32
ALDH1A1 P00352 3/20 0.32
EPAS1 Q99814 1/20 0.32
TBXA2R P21731 1/20 0.31
NPC1 O15118 1/20 0.31
RECQL P46063 1/20 0.31
RAB9A P51151 1/20 0.31
CYP1A2 P05177 1/20 0.31
GAA P10253 1/20 0.30
HTT P42858 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30772350 0.87 HSPB1 (0.39) L3MBTL1HPGDMAPTSMN1; SMN2HSPB1
SCHEMBL31448487 0.86 P2RX3 (0.39) L3MBTL1HPGDMAPTSMN1; SMN2TLR8
SCHEMBL30772368 0.81 HSPB1 (0.36) L3MBTL1MAPTSMN1; SMN2HSPB1NPSR1
SCHEMBL30772355 0.80 HPGD (0.37) HPGDMAPTSMN1; SMN2HSPB1TLR8
SCHEMBL30772367 0.80 SMN1; SMN2 (0.36) L3MBTL1MAPTSMN1; SMN2HSPB1NPSR1
SCHEMBL31448604 0.75 LMNA (0.46) L3MBTL1HPGDMAPTSMN1; SMN2TLR8
SCHEMBL31448613 0.74 P2RX3 (0.34) MAPT
SCHEMBL30772404 0.74 EPAS1 (0.42) MAPTSMN1; SMN2TLR8TDP1ALDH1A1
SCHEMBL31549911 0.73 TDP1 (0.53) L3MBTL1HPGDMAPTTDP1ALDH1A1
SCHEMBL103199 0.73 TDP1 (0.53) L3MBTL1HPGDMAPTTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND KISSEI PHARMACEUTICAL CO., LTD. (JP) 2025-11-27 US disclosed
EP-4512801-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND Kissei Pharmaceutical Co., Ltd. (JP) 2025-02-26 EP disclosed
CN-119343332-A 3, 4-Dihydro-quinolin-2 (1H) -one compounds 橘生药品工业株式会社 2025-01-21 CN disclosed
WO-2024005113-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND キッセイ薬品工業株式会社 2024-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND TSHR, TRHR, GHSR L3MBTL1 4340/4885HPGD 621/4885MAPT 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.